Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- ALTHE.PA
- Price
- 0.14
- Stock movement down
- -0.00 (-0.83%)
- Company name
- Theradiag SA
- Exchange
- (PA ,
- Currency
- EUR )
- Sector
- Healthcare >Medical Devices
- Market cap
- 6.55M
- Ent value
- 14.23M
- Price/Sales
- 1.50
- Price/Book
- 1.99
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -29.69%
- 1 year return
- -61.22%
- 3 year return
- -50.39%
- 5 year return
- -31.33%
- 10 year return
- -33.04%
Last updated: 2025-04-12
DIVIDENDS
ALTHE.PA does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 1.50 |
| Price to Book | 1.99 |
| EV to Sales | 3.26 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 45.68M |
| EPS (TTM) | -0.13 |
| FCF per share (TTM) | -0.07 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 4.36M |
| Gross profit (TTM) | -4.13M |
| Operating income (TTM) | -6.28M |
| Net income (TTM) | -6.04M |
| EPS (TTM) | -0.13 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | -94.84% |
| Operating margin (TTM) | -144.04% |
| Profit margin (TTM) | -138.52% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 3.90M |
| Net receivables | 3.08M |
| Total current assets | 12.38M |
| Goodwill | 0.00 |
| Intangible assets | 1.18M |
| Property, plant and equipment | 0.00 |
| Total assets | 14.86M |
| Accounts payable | 1.14M |
| Short/Current long term debt | 1.62M |
| Total current liabilities | 4.07M |
| Total liabilities | 11.57M |
| Shareholder's equity | 3.29M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -3.99M |
| Capital expenditures (TTM) | 1.18M |
| Free cash flow (TTM) | -3.06M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -183.51% |
| Return on Assets | -40.63% |
| Return on Invested Capital | -153.01% |
| Cash Return on Invested Capital | -77.57% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 0.14 |
| Daily high | 0.15 |
| Daily low | 0.14 |
| Daily Volume | 48K |
| All-time high | 13.35 |
| 1y analyst estimate | 7.00 |
| Beta | 0.07 |
| EPS (TTM) | -0.13 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| ALTHE.PA | S&P500 | |
| Current price drop from All-time high | -98.93% | -12.89% |
| Highest price drop | -98.93% | -56.47% |
| Date of highest drop | 11 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -75.96% | -11.07% |
| Avg time to new high | 468 days | 12 days |
| Max time to new high | 2802 days | 1805 days |
COMPANY DETAILS
Marketcap
6.55M
Marketcap category
Small-cap
Description
Theraclion SA designs and markets high-tech therapeutic ultrasound equipment. It offers SONOVEIN, a robotic solution for non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installed on the device before treatment and protects the patient's skin and optimizes the image quality. Theraclion SA was incorporated in 2004 and is based in Malakoff, France.
Employees
28
Website
Investor relations
-
SEC filings
CEO
Country
France
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
MALAKOFF, France, March 26, 2025--Regulatory News: This press release must not be published, distributed, or disseminated, directly or indirectly, in the United Kingdom, the United States of America, ...
March 26, 2025
MALAKOFF, France, February 20, 2025--Regulatory News: This press release must not be published, distributed, or disseminated, directly or indirectly, in the United Kingdom, the United States of Americ...
February 20, 2025
MALAKOFF, France, February 11, 2025--Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing a robotic platform for non-invasive high-intensity focused ultraso...
February 11, 2025
MALAKOFF, France, February 07, 2025--Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing a robotic platform for non-invasive high-intensity focused ultraso...
February 7, 2025
MALAKOFF, France, January 06, 2025--Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing a robotic platform for non-invasive high-intensity focused ultrasou...
January 6, 2025
MALAKOFF, France, October 30, 2024--Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing a robotic platform for non-invasive high-intensity focused ultrasou...
October 30, 2024
MALAKOFF, France, September 06, 2024--Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing a robotic platform for non-invasive high-intensity focused ultras...
September 6, 2024
MALAKOFF, France, June 24, 2024--Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE) (Paris:ALTHE) innovative company developing a robotic platform for non-invasive high-intensity focused u...
June 24, 2024
MALAKOFF, France, June 06, 2024--Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE innovative company developing a robotic platform for non-invasive high-intensity focused ultrasound (HIFU...
June 6, 2024